Research & Innovation

IBA has uniquely positioned itself in the radiopharmaceutical environment. Its ambition is to develop new diagnostic
tracers aimed at solving major unmet medical needs. IBA expertise is the development of radiopharmaceuticals from
research to distribution.

Research Collaborations

IBA Molecular is devoted to the future of molecular imaging. We are aligning ourselves with those committed to making the same impact on the well being of patients worldwide.

Currently, our research collaborations include such prestigious partners as:

• Albert Einstein College of Medicine, New York, NY, U.S.A.
• Cornell University, Ithaca, New York, U.S.A.
• Johns Hopkins University, Baltimore, Maryland, U.S.A
• Katholieke Universiteit, Leuven, Belgium
• Memorial Sloan-Kettering Cancer Center, New York, New York, U.S.A.
• University of California San Diego, San Diego, California, U.S.A.
• Virginia Commonwealth University, Richmond, Virginia, U.S.A.
• Vrije Universiteit, Amsterdam, Netherlands
• CNRS UMR 5536, Bordeaux, France
• INSERM U-877, Grenoble, France
• University of Ferrara, Italy
• Service hospitalier Frédéric Joliot-Curie, Orsay, France
• French atomic energy commission (CEA), Saclay, France
• University of Bordeaux II, Bordeaux, France
• IAEA Industrial Applications and Chemistry Section

What kind of partners are we looking for?

IBA Molecular is leading the future of Molecular Imaging by focusing on delivering the next generation of molecular imaging agents to patients around the world. We aim to accomplish this via our collaborative research network and are actively seeking new opportunities.
Please click here to contact our Radiopharmaceutical Development Team.